Lifetime cost of human immunodeficiency virus-related health care

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 4, 1996, Pages 371-378

  Hurley, Susan F ^a   Kaldor, John M ^b   Gardiner, Sarah ^c   Carlin, John B ^d   Assunção, Renato M ^e   Evans, David B ^f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e UNIVERSITY OF WASHINGTON   (United States)

^f WORLD BANK   (United States)

Author keywords

Acquired immunodeficiency syndrome; Costs and cost analysis; Hospital costs; Human immunodeficiency virus

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COST BENEFIT ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; HOSPITAL COST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESPAN; PATIENT CARE; PRIORITY JOURNAL; SURVIVAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029811724     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608010-00007     Document Type: Article

References (34)

1. Green J, Oppenheimer GM, Wintfeld N. The $147,000 misunderstanding: repercussions of overestimating the cost of AIDS. J Health Polit Policy Law 1994;19:69-90.
2. Hardy AM, Rauch K, Echenberg D, Morgan WM, Curran JW. The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. JAMA 1986;255:209-11.
3. Scitovsky AA, Cline M, Lee PR. Medical care costs of patients with AIDS in San Francisco. JAMA 1986;256:3103-6.
4. Rice DP. Cost-of-illness studies: fact or fiction? Lancet 1994;344:1519-20.
5. Hellinger FJ. The lifetime cost of treating a person with HIV. JAMA 1993;270:474-8.
6. Hodgson TA. Annual costs of illness versus lifetime costs of illness and implications of structural change. Drug Infect J 1988;22:323-41.
7. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definitions for AIDS among adolescents and adults. MMWR 1992;41:1-19.
8. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36:3S-14S.
9. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford, 1987.
10. Krahn M, Gafni A. Discounting in the economic evaluation of health care interventions. Med Care 1993;31:403-18.
11. Hurley SF, Kaldor JM, Carlin JB, et al. The usage and costs of health services for HIV infection in Australia. AIDS 1995; 9:777-85.
12. Hurley SF, Bond LM, Carlin JB, Evans DB, Kaldor JM. A method for estimating baseline health care costs. J Epidemiol Community Health 1995;49:525-31.
13. Australian HIV Surveillance Report, vol. 9, no. 4. Sydney: National Centre in HIV Epidemiology and Clinical Research, 1993.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. + T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. J AIDS Hum Retrovirol 1991;4:1141-7.
16. Lange N, Carlin BP, Gelfand AE. Hierarchical Bayes models for the progression of HIV infection using longitudinal CD4 T-cell numbers. J Am Stat Assoc 1992;87:615-26.
17. Taylor JM, Tan SJ, Detels R, Giorgi JV. Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals. AIDS 1991;5: 159-67.
18. Bofill M, Janossy G, Lee CA. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol 1992;88:243-52.
19. Whyte BM, Evans DB, Schreurs EJ, Cooper DA. The costs of hospital-based medical care for patients with the acquired immunodeficiency syndrome. Med J Aust 1987;147:269-72.
20. Scitovsky AA, Over M. AIDS: costs of care in the developed and the developing world. AIDS 1988;(suppl 1):S71-81.
21. Borleffs JCC, Jager JC, Poos MJJC, et al. Hospital cost for patients with HIV infection in a university hospital in The Netherlands. Health Policy 1990;16:43-54.
22. Beck EJ, Kennedy J, McKevitt C, et al. Changing use of hospital services and costs at a London AIDS referral centre, 1983-1989. AIDS 1994;8:367-77.
23. Australian Institute of Health and Welfare. Health Expenditure Bulletin no. 10. Australian Health Expenditure to 1992-93. Canberra: Australian Government Publishing Service, 1995.
24. Statistics Directorate. Purchasing power parities and real expenditures. EKS results, volume 1, 1990. Paris: Organisation for Economic Co-operation and Development: 1992.
25. Norrish A, North D, Kirkman P, Jackson R. Validity of self-reported hospital admission in a prospective study. Am J Epidemiol 1994;140:938-42.
26. Fleishman JA, Mor V. Insurance status among people with AIDS: relationships with sociodemographic characteristics and service use. Inquiry 1993;30:180-8.
27. Graham NMH, Jacobson LP, Kuo V, Chmiel JS, Morgenstern H, Zucconi SL. Access to therapy in the Multicenter AIDS Cohort Study, 1989-1992. J Clin Epidemiol 1994;47: 1003-12.
28. Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health 1991;81:1285-90.
29. McDonald AM, Crofts N, Blumer CE, et al. The pattern of diagnosed HIV infection in Australia, 1984-1992. AIDS 1994;8:513-9.
30. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q 1992;70:81-125.
31. Keeler EB, Manning WG, Newhouse JP, Sloss EM, Wasserman J. The external costs of a sedentary lifestyle. Am J Public Health 1989;79:975-81.
32. Etzioni R, Urban N, Baker M. Estimating the costs attributable to a disease with application to ovarian cancer. J Clin Epidemiol 1996;49:95-103.
33. Arnold SF. Mathematical statistics. Englewood Cliffs, NJ: Prentice-Hall, 1990.
34. Velleman PF, Hoaglin DC. Applications, basic, and computing of exploratory data analysis. Boston: Duxbury Press, 1981.